Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct 27;10(10):e0141394.
doi: 10.1371/journal.pone.0141394. eCollection 2015.

Left Ventricular Dysfunction and CXCR3 Ligands in Hypertension: From Animal Experiments to a Population-Based Pilot Study

Affiliations
Free PMC article

Left Ventricular Dysfunction and CXCR3 Ligands in Hypertension: From Animal Experiments to a Population-Based Pilot Study

Raffaele Altara et al. PLoS One. .
Free PMC article

Abstract

Detecting left ventricular (LV) dysfunction at an early stage is key in addressing the heart failure epidemic. In proteome profiling experiments in mice subjected either to aortic banding or sham, the circulating CXCR3 ligands monokine induced by interferon-γ (MIG) and interferon-γ inducible protein 10 (IP10) were 5 to 40 fold up-regulated at eight weeks. We assessed the diagnostic value of circulating NT-pro BNP and CXCR3 ligands (MIG, IP10, Interferon-inducible T-cell alpha chemo-attractant [I-TAC]) in patients with hypertension (≥140/90 mm Hg) associated with subclinical (n = 19) or symptomatic (n = 16) diastolic LV dysfunction on echocardiography and healthy controls. NT-pro BNP, MIG, IP10, I-TAC all increased (p ≤ 0.014) across the categories of worsening left ventricular dysfunction. In patients with symptomatic disease, MIG, IP10, and I-TAC increased 210% (p = 0.015), 140% (p = 0.007) and 120% (p = 0.035) more than NT-pro BNP. The optimal discrimination limits, obtained by maximizing Youden's index were 246 pmol/L, 65 pg/mL, 93 pg/mL, and 24 pg/mL, respectively. The odds ratios associated with the four biomarkers were significant (p ≤ 0.010), ranging from 4.00 for IP10 to 9.69 for MIG. With adjustment for NT-pro BNP, the CXCR3 ligands retained significance (p ≤ 0.028). Adding optimized thresholds for the CXCR3 ligands to NT-pro BNP enhanced (p ≤ 0.014) the integrated discrimination improvement and the net reclassification improvement. In conclusion, congruent with the concept that inflammation plays a key role in the pathogenesis of LV dysfunction, MIG, IP10 and I-TAC add diagnostic accuracy over and beyond NT-pro BNP.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Expression profiles of the five most up-regulated cytokines in mice 4 and 8 weeks after aortic banding compared with sham operated animals.
After transverse aortic constriction (TAC), expression profiles increased at least twice (dashed line). MIG, IP10, MIP–2, IL–16 and sICAM–1 indicate monokine induced by interferon–γ (CXCL9), interferon–γ inducible protein 10 (CXCL10), murine macrophage inflammatory protein–2, interleukin 16, and soluble intercellular adhesion molecule 1, respectively.
Fig 2
Fig 2. Circulating biomarkers in patients with subclinical and symptomatic left ventricular dysfunction, normalized to each marker’s mean in healthy controls.
The vertical axis therefore expresses the average ratio in patients relative to the mean in all healthy controls combined.

Similar articles

See all similar articles

Cited by 12 articles

See all "Cited by" articles

References

    1. Dunlay SM, Roger VL (2014) Understanding the epidemic of heart failure: past, present, and future. Curr Heart Fail Rep 11:404–415. 10.1007/s11897-014-0220-x - DOI - PMC - PubMed
    1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, et al. (2008) Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117:e25–e146. - PubMed
    1. McMurray JJ, Adamopoulous S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J 33:1787–1847. 10.1093/eurheartj/ehs104 - DOI - PubMed
    1. van Kimmenade RR, Januzzi JL Jr (2012) Emerging biomarkers in heart failure. Clin Chem 58:127–138. 10.1373/clinchem.2011.165720 - DOI - PubMed
    1. Kuznetsova T, Mischak H, Mullen W, Staessen JA (2012) Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunction. Eur Heart J 33:2342–2350. 10.1093/eurheartj/ehs185 - DOI - PMC - PubMed

Publication types

MeSH terms

Grant support

The experimental work was partly supported by the Center for Translational Molecular Medicine (http://www.ctmm.nl; TRIUMPH grant 01C-103) and the Dutch Heart Foundation. The European Union (HEALTH-2011.2.4.2-2-EU-MASCARA, HEALTH-F7-305507 HOMAGE and the European Research Council Advanced Researcher Grant-2011-294713-EPLORE), the Fonds voor Wetenschappelijk Onderzoek Vlaanderen, Ministry of the Flemish Community, Brussels, Belgium (G.0881.13 and G.088013), and the International Zinc and Lead Research Organization currently support the Studies Coordinating Centre in Leuven.
Feedback